Inotiv Correlations
NOTV Stock | USD 3.41 0.20 6.23% |
The current 90-days correlation between Inotiv Inc and Fonar is -0.04 (i.e., Good diversification). The correlation of Inotiv is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Inotiv Correlation With Market
Very weak diversification
The correlation between Inotiv Inc and DJI is 0.55 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Inotiv Inc and DJI in the same portfolio, assuming nothing else is changed.
Inotiv |
Moving together with Inotiv Stock
0.61 | VCEL | Vericel Corp Ord | PairCorr |
0.75 | VERA | Vera Therapeutics | PairCorr |
0.8 | DVAX | Dynavax Technologies | PairCorr |
0.77 | VRNA | Verona Pharma PLC | PairCorr |
0.81 | VSTM | Verastem | PairCorr |
0.86 | VTRS | Viatris | PairCorr |
Moving against Inotiv Stock
0.73 | VALN | Valneva SE ADR Downward Rally | PairCorr |
0.72 | DTIL | Precision BioSciences | PairCorr |
0.65 | ME | 23Andme Holding | PairCorr |
0.65 | DRRX | Durect | PairCorr |
0.5 | DRMA | Dermata Therapeutics | PairCorr |
0.46 | A | Agilent Technologies Earnings Call This Week | PairCorr |
0.45 | DNTH | Dianthus Therapeutics | PairCorr |
0.44 | EQ | Equillium | PairCorr |
0.38 | VCNX | Vaccinex | PairCorr |
0.77 | VIRX | Viracta Therapeutics | PairCorr |
0.73 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.65 | VINC | Vincerx Pharma | PairCorr |
0.47 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.4 | VRAX | Virax Biolabs Group | PairCorr |
0.85 | EDSA | Edesa Biotech Fiscal Year End 20th of December 2024 | PairCorr |
0.79 | VXRT | Vaxart Inc | PairCorr |
0.65 | EDIT | Editas Medicine | PairCorr |
0.59 | VTGN | VistaGen Therapeutics | PairCorr |
0.45 | VTYX | Ventyx Biosciences | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Inotiv Stock performing well and Inotiv Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Inotiv's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
FONR | 1.37 | (0.23) | 0.00 | (0.40) | 0.00 | 2.14 | 9.69 | |||
BNR | 4.51 | (0.39) | 0.00 | (0.17) | 0.00 | 11.07 | 34.58 | |||
SERA | 3.77 | (0.37) | 0.00 | (0.04) | 0.00 | 9.55 | 27.67 | |||
OLK | 0.63 | 0.17 | 0.11 | (1.71) | 0.48 | 1.58 | 4.37 | |||
LMDX | 4.74 | (0.69) | 0.00 | 0.58 | 0.00 | 11.54 | 34.05 | |||
GTH | 1.87 | (0.03) | (0.02) | 0.04 | 2.49 | 3.45 | 14.43 | |||
XGN | 3.62 | 0.51 | 0.15 | 0.49 | 3.24 | 9.62 | 24.12 | |||
SHC | 1.64 | (0.30) | 0.00 | (0.11) | 0.00 | 3.45 | 11.98 | |||
DRIO | 3.66 | (0.35) | 0.00 | (0.07) | 0.00 | 8.99 | 25.17 | |||
STIM | 4.84 | (0.23) | 0.00 | (0.02) | 0.00 | 8.33 | 59.07 |
Inotiv Corporate Management
Adrian Hardy | Executive Development | Profile | |
Fernanda Beraldi | Gen Sec | Profile | |
Mo Dastagir | Chief Officer | Profile | |
Peter Kissinger | Chairman Founder | Profile | |
Kimberly Beaty | Director Marketing | Profile | |
William Pitchford | Chief Officer | Profile |